Lactobacillus brevis alleviates the progress of hepatocellular carcinoma and type 2 diabetes in mice model via interplay of gut microflora, bile acid and NOTCH 1 signaling

Type 2 diabetes (T2DM) clinically exhibits a higher incidence of hepatocellular carcinoma (HCC), contributing to a lousy prognosis in patients harboring both diseases. Microflora-based therapy draws attention with low side effects. Accumulating evidence shows that Lactobacillus brevis can improve bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shujia, Han, Ping, Zhang, Qian, Liu, Peiyan, Liu, Jie, Zhao, Lili, Guo, Lianyi, Li, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206262/
https://www.ncbi.nlm.nih.gov/pubmed/37234174
http://dx.doi.org/10.3389/fimmu.2023.1179014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206262/
https://www.ncbi.nlm.nih.gov/pubmed/37234174
http://dx.doi.org/10.3389/fimmu.2023.1179014

Ejemplares similares